Bioisosteric approach in designing new monastrol derivatives: An investigation on their ADMET prediction using in silico derived parameters
Authors:
- Umer RashidURUmer Rashid
- Farzana Latif AnsariFAFarzana Latif Ansari
- Zaheer Ul-HaqZaheer Ul-Haq
- 1 September 2013
- journal article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 45, 202-210
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agentsEuropean Journal of Medicinal Chemistry, 2013
- Targeting the Kinesin Spindle Protein: Basic Principles and Clinical ImplicationsClinical Cancer Research, 2008
- Mitotic drug targets and the development of novel anti-mitotic anticancer drugsDrug Resistance Updates, 2007
- On Scaffolds and Hopping in Medicinal ChemistryMini-Reviews in Medicinal Chemistry, 2006
- Scaffold hoppingDrug Discovery Today: Technologies, 2004
- In silico prediction of ADME and pharmacokineticsEuropean Journal of Pharmaceutical Sciences, 2002
- Evidence that Monastrol Is an Allosteric Inhibitor of the Mitotic Kinesin Eg5Chemistry & Biology, 2002
- Evolutionary conservation of microtubule-capture mechanismsNature Reviews Molecular Cell Biology, 2002
- Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5Journal of Cell Biology, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999